Fisetin

Fisetin

SCHEMBL4466733

O=P(O)(O)O.O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12.O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Fisetin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 known ✓ P27487 1/20 0.60
ADRA1A known ✓ P35348 1/20 0.60
KDR known ✓ P35968 1/20 0.60
OPRK1 known ✓ P41145 1/20 0.60
MEN1 O00255 10/20 0.90
KMT2A Q03164 10/20 0.90
KDM4E B2RXH2 8/20 0.90
CYP3A4 P08684 8/20 0.90
HSD17B10 Q99714 8/20 0.90
MAPT P10636 7/20 0.90
TP53 P04637 6/20 0.90
ALOX15 P16050 6/20 0.90
CYP2C9 P11712 6/20 0.90
MAPK1 P28482 5/20 0.90
RECQL P46063 5/20 0.90
CASP1 P29466 4/20 0.90
CASP7 P55210 4/20 0.90
ALDH1A1 P00352 4/20 0.90
HPGD P15428 4/20 0.90
CDK5 Q00535 3/20 0.90

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fisetin SCHEMBL116861 0.95 MEN1 (1.00) MEN1KMT2AKDM4ECYP3A4HSD17B10
Fisetin SCHEMBL39454 0.95 MEN1 (1.00) MEN1KMT2AKDM4ECYP3A4HSD17B10
Fisetin SCHEMBL29381611 0.95 MEN1 (1.00) MEN1KMT2AKDM4ECYP3A4HSD17B10
Fisetin SCHEMBL29394036 0.95 MEN1 (1.00) MEN1KMT2AKDM4ECYP3A4HSD17B10
Fisetin SCHEMBL29349742 0.95 MEN1 (1.00) MEN1KMT2AKDM4ECYP3A4HSD17B10
Fisetin SCHEMBL4263659 0.93 CDK5 (1.00) MEN1KMT2AKDM4ECYP3A4HSD17B10
Robinetin SCHEMBL9063852 0.91 MEN1 (0.92) MEN1KMT2AKDM4ECYP3A4HSD17B10
Fisetin SCHEMBL4887417 0.85 MEN1 (0.81) MEN1KMT2AKDM4ECYP3A4HSD17B10
SCHEMBL119655 0.84 MEN1 (0.73) MEN1KMT2AKDM4ECYP3A4HSD17B10
SCHEMBL13598637 0.84 MEN1 (0.67) MEN1KMT2AKDM4ECYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009158007-A2 METHODS AND COMPOSITIONS FOR THERAPEUTIC TREATMENT LIMERICK BIOPHARMA, INC. (US) 2009-12-30 WO claimed